Stand up To Cancer (SU2C), a division of the Entertainment Industry Foundation (EIF), this week announced that the Hollywood community is rallying together yet again to support the sixth biennial televised fundraising special on Friday, September 7, 2018.
This year’s event, which is scheduled to come live from The Barker Hangar in Santa Monica, CA, is marking 10 years since the first telecast and 10 years of SU2C?s lifesaving research achievements.
The 2018 telecast is especially significant for SU2C, as it commemorates ten years of raising awareness and funds for innovative cancer research that is helping save lives now.
Innovative research
To date, more than $480 million has been pledged in support of SU2C?s innovative cancer research. The organization has brought together more than 1,500 of the best scientists from over 180 leading institutions with an emphasis on collaborative, multidisciplinary teams that deliver new therapies and treatments to cancer patients. Scientists work together on Stand Up To Cancer?s 24 signature ?Dream Teams,? among a total of 79 team science grants and awards, whose research is aimed at ending cancer?s reign as a leading cause of death worldwide. SU2C-funded researchers have planned, launched or completed more than 180 clinical trials involving over 12,000 patients.
The results have been exceptional.
In just under 10 years, SU2C research has contributed to FDA approval of five new cancer therapies, including treatments for breast, ovarian, and pancreatic cancers and difficult-to-treat leukemias. Additional trial results have been submitted or are nearing completion for breast, colon, ovarian, and prostate cancers and for metastatic melanoma.
Stand Up To Cancer has provided substantial funding for the study of immunotherapy in the fight against cancer, and has advanced development of technologies using blood tests to identify cancers early, imaging to understand tumor progression, and precision medicine via new laboratory tools.
SU2C?s wide-ranging scientific portfolio is overseen by a blue-ribbon scientific advisory committee chaired by Nobel Prize winner Phillip A. Sharp, PhD, Institute Professor at the Massachusetts Institute of Technology. Most grants are administered by SU2C?s Scientific Partner, the American Association for Cancer Research (AACR), the world?s first and largest professional organization dedicated to advancing cancer research.
Major League Baseball
As SU2C?s founding donor, Major League Baseball has continued to annually provide both financial support and countless opportunities to build the Stand Up To Cancer movement by encouraging fans worldwide to get involved, most notably through its two largest global events ? the MLB All-Star Game and the World Series. In addition to MLB, SU2C?s ?Luminary? donors include Bristol-Myers Squibb Company, Lustgarten Foundation for Pancreatic Cancer Research, and Mastercard. ?Visionary? donors include CVS Health, Genentech, a member of the Roche Group, and the Sidney Kimmel Foundation.
Stars and Performers
Among the confirmed stars and performers participating in this memorable event are Mahershala Ali, Kathy Bates, Katie Couric, Jennifer Garner, Tony Hale, Marg Helgenberger, Ed Helms, Ken Jeong, Marlee Matlin, Matthew McConaughey, Maria Menounos, Jillian Michaels, Trevor Noah, Dak Prescott, Italia Ricci, Rob Riggle, Karla Souza, David Spade, Keith Urban, and Reese Witherspoon.
Co-executive producer
Bradley Cooper, Academy Award?-nominated actor, will return as co-executive producer along with the renowned live-event producing team Done + Dusted, working again with the Stand Up To Cancer production team, after a successful partnership for the 2016 telecast.
?As someone whose family has been significantly touched by cancer, I am proud to again have the privilege of co-executive producing this year?s Stand Up To Cancer telecast,? said? Bradley Cooper, Co-Executive Producer of SU2C.
?This show reminds everyone that you are never alone? that there is a community of support out there when you need it most. That?s the power of SU2C. Most importantly, the telecast showcases the significant progress being made in the fight against cancer, instilling hope in those facing the disease. This one-hour broadcast unites us all to raise funds for more effective treatments to save lives now.?
?This year?s Stand Up To Cancer telecast will be full of inspiring stories and hope, uniting us all in a common cause,? said Katy Mullan, executive producer at Done + Dusted.
?We will feature the patients, survivors, doctors, nurses and researchers on the front line fighting cancer every single day, as well as highlighting the groundbreaking science that SU2C funds, changing the landscape of cancer research and saving lives. It will be a celebration of the progress that is being made and affirm that when we all come together, we can achieve great things,? Mullan added.
The first five SU2C telecasts took place on September 5, 2008, September 10, 2010, September 7, 2012, September 5, 2014, and September 9, 2016 and were made available to more than 190 countries. The Canada-inclusive SU2C telecasts aired in 2014 and 2016.
Participating Broadcasters
As in years past, a large number of broadcasting organizations, including networks like ABC, CBS, FOX, and NBC, Univision Puerto Rico, and WGN America are donating one hour of simultaneous commercial-free primetime for the SU2C broadcast.
In addition to the US broadcast, Stand Up To Cancer Canada will, for the third time, simultaneously broadcast a Canada-inclusive broadcast across four major English-language Canadian broadcasters: CBC, Citytv, CTV, and Global.
Last Editorial Review: August 16, 2018
Featured Image: On September 7, 2018 the Hollywood community unites once again to support Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF). In this image, taken during the fourth biennial fundraising telecast on Friday, September 5, 2014: Katie Couric, Alison Sweeney, Mira Sorvino, Joe Manganiello, and Jesse Tyler Ferguson. Courtesy: ? 2010 ? 2018 ABC/Image Group LA/SU2C. Used with permission.
Copyright ? 2010 ? 2018 Sunvalley Communication, LLC. All rights reserved. Republication or redistribution of Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of Sunvalley Communication. Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco?Zine, Oncozine and The Onco?Zine Brief are registered trademarks and trademarks of Sunvalley Communication around the world.
